A national analysis presented at the 2025 AHA Scientific Sessions found that patients with HIV hospitalized with cardiac implantable electronic device–related infective endocarditis had significantly lower...
A multicenter cross-sectional study presented at the American Heart Association Scientific Sessions 2025 found that one in three patients with hypertrophic cardiomyopathy experience heart failure, with...
A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...
